A significant update is the increased focus on personalized, culturally tailored DSMES programs that address social determinants of health and ensure equitable access
70% of the programs in clinical development were antiamyloid programs and anti-tau programs and 20%, 30% were alternate pathways
Food and Drug Administration (2024) FDA drug shortages, U.S
We are committed to providing you with the cleanest, most effective formulations possible
Clinical Biochemistry, 48 (16-17), 1200-1208
High-capacity advanced format The 80mg format provides significant peptide volume, making it ideal for extended workflows, repeat testing, and high-volume experimental protocols